Metabolic syndrome increases operative mortality in patients with impaired left ventricular systolic function who undergo coronary artery bypass grafting: a retrospective observational study

BACKGROUND: Metabolic syndrome (MetS) is a prevalent risk factor for coronary artery disease progression. Past studies have shown that MetS and its components tends to increase mortality after coronary artery bypass grafting (CABG), but data on the impact of MetS on postoperative outcome in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shuangkun, Li, Jiahui, Li, Qianzhen, Qiu, Zhihuang, Wu, Xijie, Chen, Liangwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343347/
https://www.ncbi.nlm.nih.gov/pubmed/30674287
http://dx.doi.org/10.1186/s12872-019-1004-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343347/
https://www.ncbi.nlm.nih.gov/pubmed/30674287
http://dx.doi.org/10.1186/s12872-019-1004-8

Ejemplares similares